TriSalus Life Sciences (TLSI) Change in Taxes (2022 - 2023)

TriSalus Life Sciences' (TLSI) quarterly Change in Taxes came in at -$24278.0 in Q2 2023, down 189.53% quarter-over-quarter from $27118.0 in Q1 2023.

TriSalus Life Sciences (TLSI) Change in Taxes (2022 - 2023) Analysis & Trends

TriSalus Life Sciences' Change in Taxes history runs 2 years deep, the most recent figure standing at -$24278.0 for Q2 2023.

On a quarterly basis, Change in Taxes changed N/A year-over-year to -$24278.0 in Q2 2023; TTM through Jun 2023 was $2492.0, a N/A change from a year earlier, with the FY2022 full-year figure at $27854.0, changed N/A from the prior year.
Change in Taxes slipped to -$24278.0 in Q2 2023 per TLSI's latest filing, from $27118.0 in the prior quarter.
Across five years, Change in Taxes topped out at $135284.0 in Q3 2022 and bottomed at -$135632.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	42.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	41.90 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	TriSalus Life Sciences	220.07 Mn	163.52 Mn	7.67 Mn	-

Download Data